Drugs / K-312
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02676830 | Aug 2014 → Feb 2015 | hyperlipidemia | Kowa Research Institute, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02676596 | Apr → Nov 2014 | hyperlipidemia | Kowa Research Institute, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01952548 | May → Dec 2013 | — | Kowa Research Institute, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K-312 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01952548 ↗ |
| Route | Oral | “Single oral dose” NCT02676830 ↗ |